Other disease hallmarks, such as tau hyperphosphorylation and inflammation, are also a source of ROS, hence the high generation of ROS in AD is likely to surpass the antioxidant capacity of cells.Strategies that can reduce the elevated ROS are potent neuroprotective strategies. Here, MAPT is linked to Alzheimer disease.